National cancer screening program for colorectal cancer in Korea.

IF 1.2 4区 医学 Q3 SURGERY
Seung Min Baik, Ryung-Ah Lee
{"title":"National cancer screening program for colorectal cancer in Korea.","authors":"Seung Min Baik, Ryung-Ah Lee","doi":"10.4174/astr.2023.105.6.333","DOIUrl":null,"url":null,"abstract":"Colorectal cancer is the 3rd leading cause of cancer-related deaths in Korea, ranking 4th and 3rd among men and women, respectively. It is also the most common cause of cancer-related deaths in women older than 64 years. This study assessed the National Cancer Screening Program for colorectal cancer and examined its efficacy in enhancing public health. The fecal occult blood test (FOBT), a traditional noninvasive colorectal cancer screening test that can be performed on an outpatient basis was replaced with the fecal immunochemical test (FIT) because of the latter's better predictive value. Since 2004, the Government of South Korea has recommended an annual FIT for people aged 50 years and older as the first step in colorectal cancer screening. Individuals who test positive on the FIT are scheduled for follow-up screening procedures, such as colonoscopy or double-contrast barium enema, whereas those who have a negative FOBT are not recommended for colonoscopy. Colonoscopy, as a screening tool in Korea, has definite merits because it is highly accessible to patients and is performed by qualified specialists. Although the domestic colorectal cancer screening rate is relatively stable, there is scope for improvement. Owing to the low cost of colonoscopy and the wealth of skilled endoscopy specialists, the number of intention-to-screen procedures for colonoscopy has increased. As Korea is rapidly becoming an ultra-elderly society, it is time to reconsider the revision of the classical screening program and recommend region-specific, cost-effective guidelines.","PeriodicalId":8071,"journal":{"name":"Annals of Surgical Treatment and Research","volume":"180 1","pages":""},"PeriodicalIF":1.2000,"publicationDate":"2023-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of Surgical Treatment and Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4174/astr.2023.105.6.333","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0

Abstract

Colorectal cancer is the 3rd leading cause of cancer-related deaths in Korea, ranking 4th and 3rd among men and women, respectively. It is also the most common cause of cancer-related deaths in women older than 64 years. This study assessed the National Cancer Screening Program for colorectal cancer and examined its efficacy in enhancing public health. The fecal occult blood test (FOBT), a traditional noninvasive colorectal cancer screening test that can be performed on an outpatient basis was replaced with the fecal immunochemical test (FIT) because of the latter's better predictive value. Since 2004, the Government of South Korea has recommended an annual FIT for people aged 50 years and older as the first step in colorectal cancer screening. Individuals who test positive on the FIT are scheduled for follow-up screening procedures, such as colonoscopy or double-contrast barium enema, whereas those who have a negative FOBT are not recommended for colonoscopy. Colonoscopy, as a screening tool in Korea, has definite merits because it is highly accessible to patients and is performed by qualified specialists. Although the domestic colorectal cancer screening rate is relatively stable, there is scope for improvement. Owing to the low cost of colonoscopy and the wealth of skilled endoscopy specialists, the number of intention-to-screen procedures for colonoscopy has increased. As Korea is rapidly becoming an ultra-elderly society, it is time to reconsider the revision of the classical screening program and recommend region-specific, cost-effective guidelines.
韩国全国大肠癌筛查计划。
大肠癌是韩国癌症相关死亡的第三大主要原因,在男性和女性中分别排名第四和第三。它也是 64 岁以上女性最常见的癌症相关死亡原因。这项研究对国家大肠癌筛查计划进行了评估,并考察了该计划在提高公众健康水平方面的功效。粪便潜血试验(FOBT)是一种可在门诊进行的传统无创大肠癌筛查试验,由于粪便免疫化学试验(FIT)具有更好的预测价值,因此被粪便免疫化学试验(FIT)所取代。自 2004 年起,韩国政府建议 50 岁及以上人群每年进行一次粪便免疫化学检测(FIT),作为大肠癌筛查的第一步。FIT 检测呈阳性者将被安排进行后续筛查,如结肠镜检查或双对比钡灌肠,而 FOBT 检测呈阴性者则不建议进行结肠镜检查。在韩国,结肠镜检查作为一种筛查工具,具有明显的优势,因为患者很容易接受,而且由合格的专家进行。虽然国内的结直肠癌筛查率相对稳定,但仍有改进的余地。由于结肠镜检查费用低廉,内镜检查专家技术精湛,结肠镜检查的意向筛查程序数量有所增加。随着韩国迅速步入超高龄社会,现在是时候重新考虑修订经典筛查方案,并推荐针对特定地区的、具有成本效益的指导方针了。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.30
自引率
7.10%
发文量
75
期刊介绍: Manuscripts to the Annals of Surgical Treatment and Research (Ann Surg Treat Res) should be written in English according to the instructions for authors. If the details are not described below, the style should follow the Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publications available at International Committee of Medical Journal Editors (ICMJE) website (http://www.icmje.org).
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信